Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancer

Cell and Bioscience

Volumn 4, Issue 1, 2014, Pages

  Kido, Tatsuo ^a   Schubert, Stephanie ^b   Hatakeyama, Shingo ^c   Ohyama, Chikara ^c   Schmidtke, Jörg ^b   Lau, Yun Fai C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

Prostate cancer; Proto oncogene; Transgenic mouse models; TSPY; Y chromosome

Indexed keywords

MUS; MUS MUSCULUS; RATTUS; SIMIAN VIRUS 40;

EID: 84897673861     PISSN: None     EISSN: 20453701     Source Type: Journal    
DOI: 10.1186/2045-3701-4-9     Document Type: Article

References (61)

1. Report of National Cancer Institute, United States. http://www.cancer.gov/cancertopics/types/prostate.
2. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003, 349:366-381. 10.1056/NEJMra021562, 12878745.
3. Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 2010, 24:1967-2000. 10.1101/gad.1965810, 2939361, 20844012.
4. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S, Michalopoulos G, Becich M, Luo JH. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 2004, 22:2790-2799. 10.1200/JCO.2004.05.158, 15254046.
5. Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, Balk SP. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 2006, 66:2815-2825. 10.1158/0008-5472.CAN-05-4000, 16510604.
6. Cunha GR, Hayward SW, Wang YZ, Ricke WA. Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 2003, 107:1-10. 10.1002/ijc.11335, 12925950.
7. Cunha GR, Hayward SW, Wang YZ. Role of stroma in carcinogenesis of the prostate. Differentiation 2002, 70:473-485. 10.1046/j.1432-0436.2002.700902.x, 12492490.
8. Hayward SW, Rosen MA, Cunha GR. Stromal-epithelial interactions in the normal and neoplastic prostate. Br J Urol 1997, 79(Suppl 2):18-26.
9. Vijayakumar S, Garcia D, Hensel CH, Banerjee M, Bracht T, Xiang R, Kagan J, Naylor SL. The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice. Genes Chromosomes Cancer 2005, 44:365-372. 10.1002/gcc.20250, 16080199.
10. Vijayakumar S, Hall DC, Reveles XT, Troyer DA, Thompson IM, Garcia D, Xiang R, Leach RJ, Johnson-Pais TL, Naylor SL. Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization. Cancer Res 2006, 66:4055-4064. 10.1158/0008-5472.CAN-05-3822, 16618725.
11. Jordan JJ, Hanlon AL, Al-Saleem TI, Greenberg RE, Tricoli JV. Loss of the short arm of the Y chromosome in human prostate carcinoma. Cancer Genet Cytogenet 2001, 124:122-126. 10.1016/S0165-4608(00)00340-X, 11172902.
12. Kuroda N, Shiotsu T, Hes O, Michal M, Shuin T, Lee GH. Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. Med Mol Morphol 2010, 43:231-234. 10.1007/s00795-009-0465-8, 21267700.
13. Tricoli JV. Y chromosome enumeration in touch preparations from 42 prostate tumors by interphase fluorescence in situ hybridization analysis. Cancer Genet Cytogenet 1999, 111:1-6. 10.1016/S0165-4608(98)00212-X, 10326583.
14. Hood L, Rowen L. The human genome project: big science transforms biology and medicine. Genome Med 2013, 5:79. 10.1186/gm483, 24040834.
15. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, Brown LG, Repping S, Pyntikova T, Ali J, Bieri T, Chinwalla A, Delehaunty A, Delehaunty K, Du H, Fewell G, Fulton L, Fulton R, Graves T, Hou SF, Latrielle P, Leonard S, Mardis E, Maupin R, McPherson J, Miner T, Nash W, Nguyen C, Ozersky P, Pepin K, Rock S, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 2003, 423:825-837. 10.1038/nature01722, 12815422.
16. Lau YF, Zhang J. Expression analysis of thirty one Y chromosome genes in human prostate cancer. Mol Carcinog 2000, 27:308-321. 10.1002/(SICI)1098-2744(200004)27:4<308::AID-MC9>3.0.CO;2-R, 10747295.
17. Tsuchiya K, Reijo R, Page DC, Disteche CM. Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet 1995, 57:1400-1407. 1801429, 8533770.
18. Salo P, Kaariainen H, Petrovic V, Peltomaki P, Page DC, de la Chapelle A. Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes Cancer 1995, 14:210-214. 10.1002/gcc.2870140309, 8589038.
19. Page DC. Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 1987, 101(Suppl):151-155.
20. Lau Y, Chou P, Iezzoni J, Alonzo J, Komuves L. Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet Cell Genet 2000, 91:160-164. 10.1159/000056838, 11173850.
21. Kersemaekers AM, Honecker F, Stoop H, Cools M, Molier M, Wolffenbuttel K, Bokemeyer C, Li Y, Lau YF, Oosterhuis JW, Looijenga LH. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol 2005, 36:512-521. 10.1016/j.humpath.2005.02.016, 15948118.
22. Arnemann J, Epplen JT, Cooke HJ, Sauermann U, Engel W, Schmidtke J. A human Y-chromosomal DNA sequence expressed in testicular tissue. Nucleic Acids Res 1987, 15:8713-8724. 10.1093/nar/15.21.8713, 306400, 3479749.
23. Zhang JS, Yang-Feng TL, Muller U, Mohandas TK, de Jong PJ, Lau YF. Molecular isolation and characterization of an expressed gene from the human Y chromosome. Hum Mol Genet 1992, 1:717-726. 10.1093/hmg/1.9.717, 1284595.
24. Kido T, Lau YF. A Cre gene directed by a human TSPY promoter is specific for germ cells and neurons. Genesis 2005, 42:263-275. 10.1002/gene.20147, 16035036.
25. Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, Fox EJ, Culhane AC, McArdle L, Fraga MF, Hughes L, Currid CA, O'Mahony F, Byrne A, Murphy AA, Moss C, McDonnell S, Stallings RL, Plumb JA, Esteller M, Brown R, Dervan PA, Easty DJ. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis 2005, 26:1856-1867. 10.1093/carcin/bgi152, 15958521.
26. Yin YH, Li YY, Qiao H, Wang HC, Yang XA, Zhang HG, Pang XW, Zhang Y, Chen WF. TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma. Br J Cancer 2005, 93:458-463. 10.1038/sj.bjc.6602716, 2361584, 16106251.
27. Lau YF, Lau HW, Komuves LG. Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet Genome Res 2003, 101:250-260. 10.1159/000074345, 14684991.
28. Kido T, Hatakeyama S, Ohyama C, Lau YF. Expression of the Y-Encoded TSPY is Associated with Progression of Prostate Cancer. Genes 2010, 1:283-293.
29. Li Y, Lau YF. TSPY and its X-encoded homologue interact with cyclin B but exert contrasting functions on cyclin-dependent kinase 1 activities. Oncogene 2008, 27:6141-6150. 10.1038/onc.2008.206, 18591933.
30. Oram SW, Liu XX, Lee TL, Chan WY, Lau YF. TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 2006, 6:154. 10.1186/1471-2407-6-154, 1526451, 16762081.
31. Kido T, Lau YF. The human Y-encoded testis-specific protein interacts functionally with eukaryotic translation elongation factor eEF1A, a putative oncoprotein. Int J Cancer 2008, 123:1573-1585. 10.1002/ijc.23697, 18649364.
32. Ittmann M, Huang J, Radaelli E, Martin P, Signoretti S, Sullivan R, Simons BW, Ward JM, Robinson BD, Chu GC, Loda M, Thomas G, Borowsky A, Cardiff RD. Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Res 2013, 73:2718-2736. 10.1158/0008-5472.CAN-12-4213, 23610450.
33. Jeet V, Russell PJ, Khatri A. Modeling prostate cancer: a perspective on transgenic mouse models. Cancer Metastasis Rev 2010, 29:123-142. 10.1007/s10555-010-9212-9, 20143131.
34. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004, 64:2270--2305.
35. Kasper S, Sheppard PC, Yan Y, Pettigrew N, Borowsky AD, Prins GS, Dodd JG, Duckworth ML, Matusik RJ. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab Invest 1998, 78(6):i-xv.
36. Ishii K, Shappell SB, Matusik RJ, Hayward SW. Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma. Lab Invest 2005, 85:1086-1103. 10.1038/labinvest.3700310, 15980886.
37. Tu WH, Thomas TZ, Masumori N, Bhowmick NA, Gorska AE, Shyr Y, Kasper S, Case T, Roberts RL, Shappell SB, Moses HL, Matusik RJ. The loss of TGF-beta signaling promotes prostate cancer metastasis. Neoplasia 2003, 5:267-277. 1502411, 12869309.
38. Vogel T, Dechend F, Manz E, Jung C, Jakubiczka S, Fehr S, Schmidtke J, Schnieders F. Organization and expression of bovine TSPY. Mamm Genome 1997, 8:491-496. 10.1007/s003359900482, 9195993.
39. Hughes JF, Skaletsky H, Pyntikova T, Graves TA, van Daalen SK, Minx PJ, Fulton RS, McGrath SD, Locke DP, Friedman C, Trask BJ, Mardis ER, Warren WC, Repping S, Rozen S, Wilson RK, Page DC. Chimpanzee and human Y chromosomes are remarkably divergent in structure and gene content. Nature 2010, 463:536-539. 10.1038/nature08700, 3653425, 20072128.
40. Mazeyrat S, Mitchell MJ. Rodent Y chromosome TSPY gene is functional in rat and non-functional in mouse. Hum Mol Genet 1998, 7:557-562. 10.1093/hmg/7.3.557, 9467017.
41. Schubert S, Dechend F, Skawran B, Kunze B, Winking H, Weile C, Romer I, Hemberger M, Fundele R, Sharma T, Schmidtke J. Silencing of the Y-chromosomal gene tspy during murine evolution. Mamm Genome 2000, 11:288-291. 10.1007/s003350010054, 10754104.
42. Kido T, Schubert S, Schmidtke J, Chris Lau YF. Expression of the human TSPY gene in the brains of transgenic mice suggests a potential role of this Y chromosome gene in neural functions. J Genet Genomics 2011, 38:181-191. 10.1016/j.jgg.2011.04.002, 21621739.
43. Schubert S, Skawran B, Dechend F, Nayernia K, Meinhardt A, Nanda I, Schmid M, Engel W, Schmidtke J. Generation and characterization of a transgenic mouse with a functional human TSPY. Biol Reprod 2003, 69:968-975. 10.1095/biolreprod.103.016501, 12773407.
44. Lau YF, Li Y, Kido T. Role of the Y-located putative gonadoblastoma gene in human spermatogenesis. Syst Biol Reprod Med 2011, 57:27-34. 10.3109/19396368.2010.499157, 21204751.
45. Cho HJ, Seiberg M, Georgoff I, Teresky AK, Marks JR, Levine AJ. Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas. J Neurosci Res 1989, 24:115-122. 10.1002/jnr.490240116, 2478718.
46. Attardi LD, Donehower LA. Probing p53 biological functions through the use of genetically engineered mouse models. Mutat Res 2005, 576:4-21. 10.1016/j.mrfmmm.2004.08.022, 16038709.
47. Freeman D, Lesche R, Kertesz N, Wang S, Li G, Gao J, Groszer M, Martinez-Diaz H, Rozengurt N, Thomas G, Liu X, Wu H. Genetic background controls tumor development in PTEN-deficient mice. Cancer Res 2006, 66:6492-6496. 10.1158/0008-5472.CAN-05-4143, 16818619.
48. Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A, Sankila A, Turunen JP, Lundin M, Konsti J, Vesterinen T, Nordling S, Kallioniemi O, Hautaniemi S, Jänne OA. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J 2011, 30:3962-3976. 10.1038/emboj.2011.328, 3209787, 21915096.
49. Mirosevich J, Gao N, Gupta A, Shappell SB, Jove R, Matusik RJ. Expression and role of Foxa proteins in prostate cancer. Prostate 2006, 66:1013-1028. 10.1002/pros.20299, 16001449.
50. Chiaverotti T, Couto SS, Donjacour A, Mao JH, Nagase H, Cardiff RD, Cunha GR, Balmain A. Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. Am J Pathol 2008, 172:236-246. 10.2353/ajpath.2008.070602, 2189611, 18156212.
51. Xin L. Cells of origin for cancer: an updated view from prostate cancer. Oncogene 2013, 32:3655-3663. 10.1038/onc.2012.541, 23178496.
52. Taylor RA, Toivanen R, Frydenberg M, Pedersen J, Harewood L, Collins AT, Maitland NJ, Risbridger GP, Australian Prostate Cancer B Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status. Stem Cells 2012, 30:1087-1096. 10.1002/stem.1094, 22593016, Australian Prostate Cancer B.
53. Wang ZA, Mitrofanova A, Bergren SK, Abate-Shen C, Cardiff RD, Califano A, Shen MM. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol 2013, 15:274-283. 10.1038/ncb2697, 3743266, 23434823.
54. Sharma P, Schreiber-Agus N. Mouse models of prostate cancer. Oncogene 1999, 18:5349-5355. 10.1038/sj.onc.1203037, 10498888.
55. Friberg S, Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol 1997, 65:284-297. 10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2, 9274795.
56. Griffiths K, Prezioso D, Turkes A, Denis LJ. The prevention of prostate cancer. Recent Results Cancer Res 2007, 175:33-63. 10.1007/978-3-540-40901-4_4, 17432553.
57. Berquin IM, Min Y, Wu R, Wu H, Chen YQ. Expression signature of the mouse prostate. J Biol Chem 2005, 280:36442-36451. 10.1074/jbc.M504945200, 16055444.
58. Gregg JL, Brown KE, Mintz EM, Piontkivska H, Fraizer GC. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection. BMC Cancer 2010, 10:165. 10.1186/1471-2407-10-165, 2876079, 20426842.
59. Ricke EA, Williams K, Lee YF, Couto S, Wang Y, Hayward SW, Cunha GR, Ricke WA. Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis. Carcinogenesis 2012, 33:1391-1398. 10.1093/carcin/bgs153, 3499049, 22535887.
60. Strand DW, Hayward SW. Modeling stromal-epithelial interactions in disease progression. Discov Med 2010, 9:504-511.
61. Kido T, Lau YF. The rat Tspy is preferentially expressed in elongated spermatids and interacts with the core histones. Biochem Biophys Res Commun 2006, 350:56-67. 10.1016/j.bbrc.2006.08.191, 1885557, 16996029.